Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only

Home/TX/Laredo

Updated October 2026 from ClinicalTrials.gov

Paid Clinical Trials in Laredo, TX

Studies commonly pay $75 to $4,500 per completed study

23 clinical trials are currently recruiting participants within 30 miles of Laredo. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

23studies recruiting

3+research centers nearby

4condition categories

Live from the NIH registry

Studies recruiting near Laredo right now

Top 25 of 23 recruiting studies, sorted by proximity — each links to its official registry page

A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors

HER2-positive Advanced Solid Tumor Phase 1, Phase 2 Interventional 796 participants sought

Oncology and Hematology of South Texas, PA — Laredo, Texas (4.1 mi) · Sponsor: DualityBio Inc.

See eligibility & contact on ClinicalTrials.gov (NCT05150691)

An Evaluation of NGM120 in a Randomized, Double-blind, Placebo-controlled Study in Participants With Colorectal Cancer Who Have Cancer Cachexia.

Colorectal Cancer, CRC (Colorectal Cancer) Phase 2 Interventional 136 participants sought

NGM Clinical Study Site — Laredo, Texas (4.1 mi) · Sponsor: NGM Biopharmaceuticals, Inc

See eligibility & contact on ClinicalTrials.gov (NCT07033026)

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

Stage I Breast Cancer Phase 3 Interventional 1,670 participants sought

Doctor's Hospital of Laredo — Laredo, Texas (4.1 mi) · Sponsor: NRG Oncology

See eligibility & contact on ClinicalTrials.gov (NCT04852887)

A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)

Carcinoma, Non-Small-Cell Lung Phase 3 Interventional 630 participants sought

Oncology & Hematology of South Texas — Laredo, Texas (4.1 mi) · Sponsor: Mirati Therapeutics Inc.

See eligibility & contact on ClinicalTrials.gov (NCT06875310)

Study of Efficacy and Safety of Tonlamarsen in Participants With a Recent Hospitalization and a Concurrent Episode of Acute Severe Hypertension

Hypertension, Acute Severe Hypertension Phase 2 Interventional 140 participants sought

Laguna Clinical Research Associates — Laredo, Texas (4.1 mi) · Sponsor: Kardigan, Inc.

See eligibility & contact on ClinicalTrials.gov (NCT07511361)

A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events

Diabetes Mellitus, Type 2, PreDiabetes N/A Interventional 7,500 participants sought

Aeres Clinical Research — Laredo, Texas (4.1 mi) · Sponsor: Cleerly, Inc.

See eligibility & contact on ClinicalTrials.gov (NCT06112418)

A Study to Evaluate the Safety and Efficacy of MK-1406/CD388 for Prevention of Influenza (MK-1406-005/CD388.SQ.3.06)

Influenza Phase 3 Interventional 10,000 participants sought

Laguna Clinical Research Associates LLC ( Site 0581) — Laredo, Texas (4.1 mi) · Sponsor: Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

See eligibility & contact on ClinicalTrials.gov (NCT07159763)

Molecular Genetics Studies of Cancer Patients and Their Relatives

Malignant Neoplasm N/A Observational 999,999 participants sought

Doctor's Hospital of Laredo — Laredo, Texas (4.1 mi) · Sponsor: City of Hope Medical Center

See eligibility & contact on ClinicalTrials.gov (NCT04185935)

Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy

Cancer Weight Loss Phase 2 Interventional 120 participants sought

Laguna Clinical Research Associates — Laredo, Texas (4.1 mi) · Sponsor: Endevica Bio

See eligibility & contact on ClinicalTrials.gov (NCT06937177)

A Multicenter, Randomized, Double-Masked, Placebo-Controlled Pilot Study to Evaluate the Efficacy and Safety of ZOC2017217 in Subjects With Age-Related Cataract

Age Related Cataracts Phase 2 Interventional 40 participants sought

Valley Retina Institute P.A. — Laredo, Texas (4.1 mi) · Sponsor: Ocusun Ophthalmic Pharmaceutical (Guangzhou) Co., Ltd.

See eligibility & contact on ClinicalTrials.gov (NCT07395986)

Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)

Atrial Fibrillation (AF) Phase 3 Interventional 2,500 participants sought

Anthos Investigative Site 9901 — Laredo, Texas (4.1 mi) · Sponsor: Anthos Therapeutics, Inc.

See eligibility & contact on ClinicalTrials.gov (NCT05712200)

Enhancing Cognitive and Work/School Outcomes in First Episode Psychosis Using Cognitive Self-Management Strategies

First Episode Psychosis (FEP) N/A Interventional 60 participants sought

Border Region Behavioral Health Care — Laredo, Texas (4.1 mi) · Sponsor: Boston University Charles River Campus

See eligibility & contact on ClinicalTrials.gov (NCT07749105)

A Study on the Efficacy of a Vaccine Against Influenza in Adults ≥65 Years of Age

Influenza, Human Phase 3 Interventional 54,000 participants sought

GSK Investigational Site — Laredo, Texas (4.1 mi) · Sponsor: GlaxoSmithKline

See eligibility & contact on ClinicalTrials.gov (NCT07805707)

Patient Retrospective Outcomes (PRO)

Chronic Pain N/A Observational 15,000 participants sought

Advanced Spine Pain Solutions — Laredo, Texas (4.1 mi) · Sponsor: Boston Scientific Corporation

See eligibility & contact on ClinicalTrials.gov (NCT01550575)

MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study

Lumbar Spinal Stenosis N/A Observational 8,000 participants sought

Laredo Medical Center — Laredo, Texas (4.1 mi) · Sponsor: Stryker Instruments

See eligibility & contact on ClinicalTrials.gov (NCT03072927)

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Multiple conditions N/A Observational 2,000 participants sought

Doctor's Hospital of Laredo — Laredo, Texas (4.1 mi) · Sponsor: Alliance for Clinical Trials in Oncology

See eligibility & contact on ClinicalTrials.gov (NCT05334069)

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

End Stage Kidney Disease Phase 2, Phase 3 Interventional 3,110 participants sought

Laguna Clinical Research Associates, LLC — Laredo, Texas (4.1 mi) · Sponsor: CSL Behring

See eligibility & contact on ClinicalTrials.gov (NCT05485961)

Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program

Cigarette Smoking-Related Carcinoma Phase 3 Interventional 600 participants sought

Doctor's Hospital of Laredo — Laredo, Texas (4.1 mi) · Sponsor: Alliance for Clinical Trials in Oncology

See eligibility & contact on ClinicalTrials.gov (NCT05008848)

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

Triple-Negative Breast Cancer Phase 3 Interventional 1,530 participants sought

Laguna Clinical Research Associates LLC ( Site 0068) — Laredo, Texas (4.1 mi) · Sponsor: Merck Sharp & Dohme LLC

See eligibility & contact on ClinicalTrials.gov (NCT06393374)

Evexomostat Plus PI3K or AKT Inhibitor and Fulvestrant in Patients With a PI3K Alteration and HR+/Her2- Breast Cancer

HR+/HER2-negative Breast Cancer, Metastatic Breast Cancer Phase 1, Phase 2 Interventional 52 participants sought

Doctors Hospital of Laredo — Laredo, Texas (4.1 mi) · Sponsor: SynDevRx, Inc.

See eligibility & contact on ClinicalTrials.gov (NCT05455619)

ONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 Inhibitors

Non Small Cell Lung Cancer Phase 3 Interventional 630 participants sought

Oncology and Hematology of South Texas - 1165 — Laredo, Texas (4.1 mi) · Sponsor: OncoC4, Inc.

See eligibility & contact on ClinicalTrials.gov (NCT05671510)

Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

High Risk Cardiovascular Disease, Hypertension Phase 3 Interventional 11,000 participants sought

Clinical Trial Site — Laredo, Texas (4.1 mi) · Sponsor: Alnylam Pharmaceuticals

See eligibility & contact on ClinicalTrials.gov (NCT07181109)

A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)

Coronavirus Disease (COVID-19) Phase 3 Interventional 3,082 participants sought

Andres Garcia Zuniga, M.D., P.A. ( Site 3782) — Laredo, Texas (4.1 mi) · Sponsor: Merck Sharp & Dohme LLC

See eligibility & contact on ClinicalTrials.gov (NCT06667700)

Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors

Melanoma (Skin Cancer), HER2-low Hormone Receptor Positive Breast Cancer Phase 1, Phase 2 Interventional 92 participants sought

Laguna Clinical Research Associates — Laredo, Texas (4.1 mi) · Sponsor: Aminex Therapeutics, Inc.

See eligibility & contact on ClinicalTrials.gov (NCT07287917)

A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight

Obesity, Type 2 Diabetes Phase 3 Interventional 2,500 participants sought

Aeres Clinical Research — Laredo, Texas (4.1 mi) · Sponsor: Novo Nordisk A/S

See eligibility & contact on ClinicalTrials.gov (NCT07564414)

Actively enrolling

Studies you may be able to join near Laredo

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

See which clinical studies you may qualify for

A partner research network matches volunteers with studies that are currently enrolling in the United States. You answer a few screening questions about your health and where you live; if a study looks like a fit, its team contacts you to confirm eligibility.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Google-rated

Top-rated research centers in Laredo

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Aeres Clinical Research

1519 Bustamante St # B, Laredo, TX 78041

(956) 763-9713

Website

UT Health Science Center Regional Campus - Laredo

★ 4.7

1937 Bustamante St, Laredo, TX 78041

(956) 523-7473

"It is a great venue for large group functions. Had several addtional class rooms. It was very nice inside and out. We were there for an Alzheimers f…"

— Thomas Brittain, 4★

Chanderbhan Psychological Services

★ 4.6 (40 reviews)

5219 McPherson Rd 312 Floor 3, Laredo, TX 78041

(956) 898-1595

Website

"Dr. Chanderbhan was great. Verry knowledgeable, professional, organized and familiar with the medical process that CBP requires for their evaluation.…"

— Mathew Munoz, 5★

Clinical trials in Laredo: what's recruiting

The Laredo area currently has 23 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Laredo, the most active research areas are:

Cancer & Oncology11 studies
Diabetes & Metabolism3 studies
Heart & Vascular2 studies
Liver & Kidney2 studies

Every listing shows the study phase, the recruiting site and its distance from Laredo, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Laredo

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Laredo participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Laredo pay?

Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.

Do I need to be sick to join a clinical trial in Laredo?

No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.

Are clinical trials in Laredo safe?

Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.

How do I join a study in Laredo, TX?

Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.

Can I be in more than one clinical trial at a time?

Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Laredo typically complete one or two studies per year.

Paid clinical trials near Laredo

Other metros within reach

McAllen, TX137 Corpus Christi, TX70 San Antonio, TX1,015 Brownsville, TX61 Austin, TX751 Killeen, TX106 College Station, TX46 Waco, TX54

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Laredo Bladder Issues Due To Spinal Cord Injury in Laredo All conditions

More of TX

Houston3,077 Pasadena3,010 Irving2,008 Grand Prairie1,978 Arlington1,893 Dallas1,887 Garland1,848 Plano1,839 Frisco1,838 Mesquite1,788 San Antonio1,015 Austin751

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

Get free trial alerts